C WorldWide Group Holding A/S - Q3 2017 holdings

$7.03 Billion is the total value of C WorldWide Group Holding A/S's 165 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was - .

 Value Shares↓ Weighting
ZBH NewZIMMER BIOMET HLDGS INC$6,983,00059,639
+100.0%
0.10%
NUVA NewNUVASIVE INC$5,259,00094,827
+100.0%
0.08%
STML NewSTEMLINE THERAPEUTICS INC$1,776,000160,000
+100.0%
0.02%
HRTX NewHERON THERAPEUTICS INC$1,615,000100,000
+100.0%
0.02%
PGR NewPROGRESSIVE CORP OHIO$1,375,00028,400
+100.0%
0.02%
ANTM NewANTHEM INC$950,0005,000
+100.0%
0.01%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-06
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VISA INC37Q3 202315.5%
THERMO FISHER SCIENTIFIC INC37Q3 202311.2%
HDFC BANK LTD37Q3 20233.7%
ICICI BK LTD37Q3 20232.1%
CENTENE CORP DEL37Q3 20230.4%
DEX INC37Q3 20230.5%
BIOMARIN PHARMACEUTICAL INC37Q3 20230.3%
VERTEX PHARMACEUTICALS INC37Q3 20230.4%
INSULET CORP37Q3 20230.3%
CARA THERAPEUTICS INC37Q3 20230.2%

View C WorldWide Group Holding A/S's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-03
13F-HR2024-02-05
13F-HR2023-11-03
13F-HR2023-08-02
13F-HR2023-05-02
13F-HR2023-02-03
13F-HR2022-11-03
13F-HR2022-08-02
13F-HR2022-05-04
13F-HR2022-02-02

View C WorldWide Group Holding A/S's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (7033694000.0 != 7035056000.0)

Export C WorldWide Group Holding A/S's holdings